POINT-OF-CARE COAGULATION TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-22051 |   Pharmaceuticals

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Point-of-Care Coagulation Testing Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET

7.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Getein Biotech, Inc.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Siemens Healthcare

16.3 ILine Microsystems

16.4 Diagon

16.5 Abbott Laboratories

16.6 Accriva Diagnostics

16.7 Alere

16.8 TaiDoc Technology Corporation

16.9 Callegari Srl

16.10 Goldsite Diagnostics Inc

16.11 F.Hoffmann-La Roche

16.12 CoaquSense

16.13 Medtronic

16.14 Sysmex

16.15 Micropoint Bioscience

16.16 Helena Point of Care

16.17 HemoSonics

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Most important types of Point-of-Care Coagulation Testing products covered in this report are:
Prothrombin Time/International Normalized Tatio (PT-INR) Testing
Bleeding Time Testing
Fibrinogen Level Testing
Others

Most widely used downstream fields of Point-of-Care Coagulation Testing market covered in this report are:
Retail Prices
Hospitals
Clinics
Health Centers
Homecare Settings

Companies

Getein Biotech, Inc.
Siemens Healthcare
ILine Microsystems
Diagon
Abbott Laboratories
Accriva Diagnostics
Alere
TaiDoc Technology Corporation
Callegari Srl
Goldsite Diagnostics Inc
F.Hoffmann-La Roche
CoaquSense
Medtronic
Sysmex
Micropoint Bioscience
Helena Point of Care
HemoSonics

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.